Literature DB >> 6145594

Lack of effect of prenalterol on dialysis-associated hypotension.

J Ladefoged.   

Abstract

Prenalterol, a cardio selective beta adrenergic receptor antagonist was given perorally in doses from 20-150 mg/day in three patients with dialysis associated hypotension. No effect on blood pressure was seen over several months during this treatment.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6145594     DOI： 10.1007/bf00548774

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


  4 in total

1.  Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62.

Authors:  G Johnsson; L Jordö; P Lundborg; O Rönn; I Welin-Fogelberg; J Wikstrand
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

Review 2.  Neurologic disorders in renal failure.

Authors:  H R Tyler
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

3.  Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension.

Authors:  E S Kersh; S J Kronfield; A Unger; R W Popper; S Cantor; K Cohn
Journal:  N Engl J Med       Date:  1974-03-21       Impact factor: 91.245

4.  Cardiovascular effects of prenalterol (H133/22) in normal man.

Authors:  D H Scott; G R Arthur; R N Boyes; D B Scott
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.